Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Addiction Medicine
|
February 27, 2016
Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
Erik W Gunderson, Michael Sumner
International Wound Journal
|
March 20, 2013
A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers
Keith Harding, Michael Sumner, Matthew Cardinal
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 26, 2018
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers
Martin Jönsson, Gill Mundin, Michael Sumner
Clinical Therapeutics
|
September 29, 2015
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial
Erik W Gunderson, Peter Hjelmström, Michael Sumner, et al.
Journal of Addiction Medicine
|
March 30, 2017
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study
Kent Hoffman, Marvin L Peyton, Michael Sumner
Hospital Practice (1995)
|
July 23, 2016
Compartment syndrome of the deltoid: a case report of a common presentation in a rare location
Andrew Harrison, Michael Sumner, Jeffrey Sobecki, et al.
Digestive Diseases and Sciences
|
September 1, 2011
Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database
Sunanda V Kane, Michael Sumner, Dory Solomon, et al.
Journal of Addictive Diseases
|
June 9, 2016
Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
Lynn Webster, Peter Hjelmström, Michael Sumner, et al.
Expert Opinion on Pharmacotherapy
|
May 23, 2007
Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors
Jennifer M Stephens, Ashish V Joshi, Michael Sumner, et al.
Plos One
|
September 14, 2017
Bio-physical characterisation of polynyas as a key foraging habitat for juvenile male southern elephant seals (Mirounga leonina) in Prydz Bay, East Antarctica
Veda Malpress, Sophie Bestley, Stuart Corney, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Addiction Medicine
|
February 27, 2016
Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
Erik W Gunderson, Michael Sumner
International Wound Journal
|
March 20, 2013
A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers
Keith Harding, Michael Sumner, Matthew Cardinal
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 26, 2018
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers
Martin Jönsson, Gill Mundin, Michael Sumner
Clinical Therapeutics
|
September 29, 2015
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial
Erik W Gunderson, Peter Hjelmström, Michael Sumner, et al.
Journal of Addiction Medicine
|
March 30, 2017
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study
Kent Hoffman, Marvin L Peyton, Michael Sumner
Hospital Practice (1995)
|
July 23, 2016
Compartment syndrome of the deltoid: a case report of a common presentation in a rare location
Andrew Harrison, Michael Sumner, Jeffrey Sobecki, et al.
Digestive Diseases and Sciences
|
September 1, 2011
Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database
Sunanda V Kane, Michael Sumner, Dory Solomon, et al.
Journal of Addictive Diseases
|
June 9, 2016
Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
Lynn Webster, Peter Hjelmström, Michael Sumner, et al.
Expert Opinion on Pharmacotherapy
|
May 23, 2007
Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors
Jennifer M Stephens, Ashish V Joshi, Michael Sumner, et al.
Plos One
|
September 14, 2017
Bio-physical characterisation of polynyas as a key foraging habitat for juvenile male southern elephant seals (Mirounga leonina) in Prydz Bay, East Antarctica
Veda Malpress, Sophie Bestley, Stuart Corney, et al.
Page
of 3